Stocks Health care ENLV
NASDAQ · Health careEnlivex Ltd. (ENLV)
In fiscal 2025 capital spending exceeded operating cash flow by $10.5M. At December 31, 2025 it held $1.9M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 25, 2026.
Key facts about Enlivex Ltd.
- Net worth
- Enlivex Ltd. has a market value (market cap) of $21M at the latest share price, and shareholders' equity of $1.9B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $10.4M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 25, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Enlivex Ltd. does
Enlivex Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ENLV.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | $1.2B | $25.48 | -$10.5M |
| 2024 | n/a | -$15M | -$0.73 | -$13.1M |
| 2023 | n/a | -$29.1M | -$1.56 | -$23.8M |
| 2022 | n/a | -$31.1M | -$1.69 | -$32.1M |
| 2021 | n/a | -$14.5M | -$0.81 | -$19.2M |
| 2020 | n/a | -$11.8M | -$0.90 | -$12M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Enlivex Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 2, 2026
- October 1, 2026
- September 29, 2026
- September 25, 2026
- September 22, 2026
- August 13, 2026Passive stake (5% or more) SCHEDULE 13G
- August 11, 2026
- August 6, 2026Form F-3 filing F-3
- July 30, 2026
- July 29, 2026
Insider trades
What the people running Enlivex Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns ENLV
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Lind Global Asset Management XIV, LLC13G, passive with 2 related filers | 9.99% | August 13, 2026 |
Largest institutional holders
Insiders
Questions about ENLV
What does Enlivex Ltd. do?
Enlivex Ltd. is a company in the Health care sector, listed on NASDAQ as ENLV. Its shares trade on NASDAQ under the ticker ENLV.
What is Enlivex Ltd.'s net worth?
Enlivex Ltd. has a market value (market cap) of $21M at the latest share price, and shareholders' equity of $1.9B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Enlivex Ltd. profitable?
Yes. In fiscal 2025 it reported net income of $1.2B.
When did Enlivex Ltd. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 25, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update (amended) from October 2, 2026.
Similar companies
Compare ENLV with
Follow ENLV
Get an email when Enlivex Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Enlivex Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.